Qualitative Validation of Patient-Reported Outcomes (PRO) Instrument
Qualitative Patient Interviews to Develop a Patient-Reported Outcomes (PRO) Instrument to Assess Visual Symptoms in KAMRA® Inlay Patients
1 other identifier
observational
22
0 countries
N/A
Brief Summary
The purpose of this study is to conduct concept elicitation and cognitive debriefing interviews with patients who have been implanted with the KAMRA inlay in order to assess the content validity of a PRO instrument
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 22, 2017
CompletedFirst Submitted
Initial submission to the registry
November 9, 2017
CompletedFirst Posted
Study publicly available on registry
May 25, 2018
CompletedMay 25, 2018
May 1, 2018
1.1 years
November 9, 2017
May 23, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
PRO instrument
Develop PRO instrument that will assess KAMRA inlay-related visual symptoms and to establish the content validity of that PRO instrument.
6 months
Eligibility Criteria
The sample recruited will reflect the target KAMRA inlay patient population. Thus, a minimum of 20 subjects (up to 50 subjects to achieve saturation) who have been implanted with the KAMRA inlay will be recruited from up to 5 sites across the US. Subjects with a range of post-operative experience, satisfaction, visual symptoms, ages and educational abilities will be recruited. In addition, subjects who are of non Caucasian ethnicity will be included.
You may qualify if:
- Minimum 45 years of age, maximum age 60 years;
- Subject has been implanted with the KAMRA inlay;
- Subject is in good general health, as evidenced by medical history;
- Subject is willing and able to attend and participate in the interviews and demographic questionnaire (fluent in U.S. English); and
- Signed informed consent document.
You may not qualify if:
- Subject has severe neurological or cognitive deficits or an uncontrolled psychiatric condition that might affect their ability to participate in the interview;
- Subject has insufficient ability to read or write that would prevent them from completing a questionnaire without help;
- Subject is not a fluent speaker of U.S. English; or
- Subject is unable to attend the interview.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AcuFocus, Inc.lead
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2017
First Posted
May 25, 2018
Study Start
June 1, 2016
Primary Completion
June 22, 2017
Study Completion
June 22, 2017
Last Updated
May 25, 2018
Record last verified: 2018-05